All stock lists
ConnectOne Bancorp, Inc. (NASDAQ:CNOB)
US · Delayed Price · Currency is USD
Financial Services · Banks - Regional
32.61+0.04 (+0.12%)
Market cap
$1.64B
Insider Score
Health Score
Analyst consensus
Listed since
Apr 4, 1994
Website
Insider Score
––Not scored
CNOB Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CNOB analyst forecast
CNOB analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CNOB 12-month price target
$37.00+13.5% upsideaverage of 1 firm
$37.00High
$37.00Low
CNOB ratings mix, last 12 months
Buy Hold Sell
Best analysts covering CNOB
- Keefe, Bruyette & Woods100%success rate · +17.3% avg return · 6 calls
- Piper Sandler100%success rate · +1.7% avg return · 2 calls
- Raymond James40%success rate · -14.6% avg return · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CNOB analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Raymond James | Outperform | $37.00 | +13.2% | Upgraded | 2026-10-26 | |
| — | Raymond James | Market Perform | — | — | Downgraded | 2026-07-01 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-06-26 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-04-24 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-01-30 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2025-04-25 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Upgraded | 2025-03-26 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-12-04 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-07-26 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-07-26 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Downgraded | 2024-05-31 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2024-04-26 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2024-01-29 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2024-01-26 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-01-26 |
| — | Raymond James | Strong Buy | — | — | Upgraded | 2023-07-31 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2023-05-01 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2023-04-06 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-01-30 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2022-08-02 |
| — | Raymond James | Outperform | — | — | Reiterated | 2022-07-07 |
| — | Raymond James | Outperform | — | — | Reiterated | 2022-04-29 |
| — | Raymond James | Outperform | — | — | Downgraded | 2022-01-31 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2021-07-30 |
| — | Seaport Global | Buy | — | — | Reiterated | 2021-02-18 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2021-01-29 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2020-12-17 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2020-07-31 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2020-05-01 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2020-01-02 |
| — | Stephens & Co. | Overweight | — | — | Upgraded | 2019-07-09 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2018-04-03 |
| — | FBR Capital | Outperform | — | — | Reiterated | 2016-06-01 |
| — | PiperJaffray | Overweight | — | — | Reiterated | 2016-03-07 |
| — | Maxim Group | Buy | — | — | Reiterated | 2015-12-15 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2015-07-28 |
| — | Keefe Bruyette & Woods | Outperform | — | — | Reiterated | 2015-07-28 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2015-04-28 |
| — | Keefe Bruyette & Woods | Outperform | — | — | Reiterated | 2015-04-28 |
| — | Sterne Agee | Buy | — | — | Upgraded | 2014-10-15 |
| — | Guggenheim | Buy | — | — | Reiterated | 2014-07-09 |
| — | Raymond James | Buy | — | — | Downgraded | 2014-01-08 |
| — | Keefe Bruyette & Woods | Outperform | — | — | Reiterated | 2013-03-11 |
CNOB earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-01-29 | 0.74 | 0.83 | $115.2M | $114.6M |
| 2026-04-23 | 0.73 | 0.75 | $115.5M | $116.6M |
| 2026-07-23 | 0.82 | 0.84 | $121.5M | $122.8M |
| 2026-10-22 | 0.85 | 0.95 | $125.4M | $117.3M |
| 2027-02-04Upcoming | 0.82 | — | $127.9M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.